FDA Inspection 1273460 — Private Label Skin Care

Private Label Skin Care — FEI 3015274499

The FDA completed an inspection of Private Label Skin Care on June 23, 2025 in Canoga Park, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 23, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Canoga Park, CA (United States)

Citations

IDCFRDescription
189121 CFR 211.165(f)Failing drug products not rejected
202821 CFR 211.192Extent of discrepancy, failure investigations
439121 CFR 211.180(e)(2)Items to cover on annual reviews